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Introduction: Depression has emerged as the most prevalent mental disorder in patients 
with fibromyalgia. Stress, whose stages are alarm, resistance, near-exhaustion and exhaus-
tion, constitutes a physical reaction to a threatening situation.
Objective: To investigate the levels of stress, anxiety and depression in women with fibromy-
algia, comparing them with those of healthy women.
Patients and methods: Participants were 50 women, 25 with a diagnosis of fibromyalgia ac-
cording to the criteria of the American College of Rheumatology, and 25 without this diag-
nosis, matched for age. Instruments used: Lipp Inventory of Stress Symptoms for Adults 
(LISS), State-Trait Anxiety Inventory (STAI) and Beck Depression Inventory (BDI).
Results: The mean age was 49.36 years for the group with fibromyalgia (FM) and 49.20 years 
for the group without fibromyalgia (non-FM). FM showed a higher incidence of stress (96%) 
compared with non-FM (5%). The resistance phase was predominant in both groups, FM 
(42%) and non-FM (100%). In FM there was distribution of the four stages (alarm, resistance, 
near-exhaustion and exhaustion). The differences between phases in the analyzed groups 
were significant (p < 0.001). FM showed predominance of psychological symptoms (54%); 
non-FM did show the same frequency of psychological and physical/psychological (40%) 
symptoms. Symptoms of state and trait anxiety and of depression in FM were significantly 
higher, when compared with non-FM (p < 0.01).
Conclusion: Stress index (96%), trait anxiety (over 50) and clinically relevant depression 
(greater than 20) in FM were relevant. The understanding of the emotional variables in-
volved in fibromyalgia is important to define the therapeutic strategy. 
© 2014 Elsevier Editora Ltda. All rights reserved.
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Investigação do estresse, ansiedade e depressão em mulheres com 
fibromialgia: um estudo comparativo
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Introdução: A depressão tem se apresentado como o transtorno mental mais prevalente em 
pacientes com fibromialgia. O estresse, cujas fases são alarme, resistência, quase-exaustão 
e exaustão, constitui importante reação do organismo frente a uma situação ameaçadora.
Objetivo: Investigar os índices de estresse, ansiedade e depressão em mulheres com fibro-
mialgia, comparando-os com os de mulheres saudáveis. 
Pacientes e métodos: Participaram 50 mulheres, 25 com o diagnóstico de fibromialgia, segun-
do os critérios do American College of Rheumatology, e 25 sem o diagnóstico, pareadas 
por idade. Instrumentos utilizados: Inventário de Sintomas de Stress para Adultos de Lipp 
(ISSL), Inventário de Ansiedade Traço-Estado (IDATE) e Inventário de Depressão Beck (BDI). 
Resultados: Idade média de 49,36 anos para o grupo com fibromialgia (FM) e 49,20 anos para 
o grupo sem fibromialgia (não FM). O FM apresentou maior incidência de estresse (96%) 
quando comparado com o não FM (5%). A fase de resistência foi predominante nos dois 
grupos, FM (42%) e não FM (100%). No FM verificou-se distribuição nas quatro fases (alerta, 
resistência, quase-exaustão e exaustão). As diferenças entre as fases nos grupos analisados 
foram significativas (p<0,001). O FM apresentou predominância de sintomas psicológicos 
(54%), o não FM apresentou a mesma frequência de sintomas psicológico e físico/psicoló-
gico (40%). Os sintomas de ansiedade estado e traço e depressão do FM foram significativa-
mente superiores, quando comparados com o não FM (p<0,01). 
Conclusão: Constatou-se índice de estresse (96%), traço de ansiedade (superior a 50) e de-
pressão clinicamente (superior a 20) relevantes no FM. O entendimento das variáveis emo-
cionais envolvidas na fibromialgia é importante na definição da terapêutica.
© 2014 Elsevier Editora Ltda. Todos os direitos reservados.
Introduction
Fibromyalgia is a complex syndrome characterized by diffuse 
and chronic musculoskeletal pain, and by specific painful sites 
on palpation, called tender points.1 This syndrome is most 
prevalent in women aged between 40 and 55 years.2 Other 
symptomatic aspects are fatigue, morning stiffness, sleep dis-
turbances, cognitive impairment, depression and anxiety.2-7 
Among the mental disorders, the latter two appear as the most 
prevalent.2,3,8,9
The negative impact of fibromyalgia on quality of life is evi-
dent,3 a fact that causes the presence of high levels of stress, 
especially in women with this disease, compared with those 
without this diagnosis.10 In addition, studies show that women 
are more exposed to stress situations, both for its biological 
condition as for the cultural roles that, historically, society im-
poses on them.11,12
Psychopathological processes, such as depression and anxi-
ety, are related both to the characteristics of the stressor event 
and to the cognitive processing used by the individual to inter-
pret them, as central elements of stress.13 Therefore, it is evi-
dent the role of cognitive mediation in triggering the stress and 
its effects, as well as in its confrontation.14-16
In this study, stress is understood as a set of complex psy-
chophysiological and behavioral responses, the genesis of 
which is in the need to establish the body's internal homeo-
stasis, when facing a threatening situation.14 The imbalance 
occurs when the body needs to respond to any demand that 
exceeds its adaptive capacity. Significant changes generate the 
need of adaptation of the organism and thus exert a decisive 
role in the pathogenesis of stress.13,14,17 In fibromyalgia, it can be 
stated that all of its symptoms are beyond the adaptive capac-
ity of the organism.2,3,10
The three-phase evolution model of stress, proposed by 
Hans Selye in 1956, suggests that the stress process comprises 
three phases: alarm, resistance and exhaustion.13 However, 
in the validation of the Lipp Inventory of Stress Symptoms 
of Adults (LISS), a fourth phase was identified, between resis-
tance and exhaustion, which was called near-exhaustion.18 
At this point, the individual demonstrates significant clinical 
symptomatology, although has not reached complete exhaus-
tion yet. It is noteworthy that the alert phase is considered the 
positive phase of stress. The body produces adrenaline and 
noradrenaline, generating energy and motivation. The homeo-
stasis breakdown at this stage does not seek to maintain, but to 
cope, with the challenging situation. However, if stress persists, 
the resistance phase will be induced. During the body attempt 
of adaptation, the individual begins to show a feeling of waste 
and fatigue. If the stressor event persists, the body's energy re-
serve ends up exhausted, affecting the immune system.13,18
Considering the impact of the variables of emotional order 
in the aggravation of the symptoms of fibromyalgia, and seek-
ing to deepen the understanding of such variables, this study 
aimed to investigate the indexes of stress, anxiety and depres-
sion in women with fibromyalgia versus healthy women.
Patients and methods 
This is a cross-sectional comparative study of quantitative 
approach. The research was conducted in accordance with 
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Table 1 – Descriptive measures of the variables anxiety, 
depression and stress in each study group.
FM non-FM
Mean SD Mean SD p
STAI - S 42.88 14.73 34.04 8.71 0.014
STAI - T 52.96 14.10 36.64 12.39 0.001
BDI 21.48 11.87 7.36 8.12 0.001
LISS (Q1) 6.92 10.93 1.44 1.33 0.001
LISS (Q2) 8.16 30.44 2.40 2.63 0.001
LISS (Q3) 11.20 40.42 2.40 2.74 0.001
STAI – S, Trait Anxiety Inventory – State; STAI – T, Trait Anxiety 
Inventory – Trait; BDI, Beck Depression Inventory; LISS (Q1), alert 
phase; LISS (Q2), resistance phase and near-exhaustion; LISS (Q3), 
exhaustion phase.
the Resolution of the Ministério da Saúde No. 196/96 of the 
Conselho Nacional de Saúde and with the deliberation of 
the Ethics Committee of UNIFESP (CEP 1785/10).
Sample
The study included 50 women divided into two groups: 25 
with a diagnosis of fibromyalgia (FM), according to the crite-
ria of the American College of Rheumatology (ACR),1 coming 
from a university medical school, and 25 without a diagnosis 
of fibromyalgia (non-FM), matched for age and coming from 
the community. The inclusion criteria were: age between 20 
and 65 years, absence of cognitive deficits and interest in 
participating in the study. For the sample size,  a minimum 
significant difference between groups of 10 points on the 
Beck Depression Inventory (BDI) was defined.19 BDI was set 
as a criterion for performing the sample size calculation, be-
cause depression is one of the most common comorbidities 
in patients with fibromyalgia.2,3,8
We established the standard deviation of 8.7 points for 
the fibromyalgia group and 4.3 for the group without such 
a diagnosis. With a significance level at 0.05 and a power 
of 80%, it was found that the sample should have at least 
24 subjects in each group.20 Thus, a total of 25 women in 
each group met the criteria of sample size calculation, and 
also made possible a safety margin in the recruitment of the 
number of voluntaries.
Instruments
A) Lipp Inventory of Stress Symptoms for Adults (LISS).18 Com-
prising a list of physical and psychological symptoms which 
identify if the person has stress, at what phase of the pro-
cess (alarm, resistance, near-exhaustion and exhaustion) 
and if his (her) symptoms are more typical of the physi-
cal or psychological dimension. LISS is structured in three 
sections dealing with the four phases of stress: sector 1 
evaluates the alert phase (Q1); sector 2 evaluates the resis-
tance phase and the phase of near-exhaustion (Q2); sector 
3, the exhaustion phase (Q3), which enables the diagnosis 
of stress. The respondent is asked to indicate whether is 
suffering the specified stress symptom in each sector in 24 
hours (Q1), one week (Q2) or a month (Q3). The evaluation is 
made in terms of the test’s percentage tables. The presence 
of stress can be seen if any of the raw scores reach certain 
limits (greater than 6 in Q1, greater than 3 in Q2, greater 
than 8 in Q3). 
B) State-Trait Anxiety Inventory (STAI) .21 It consists of 
two scales for measuring trait anxiety (STAI-T) and state 
anxiety (STAI-E). Each scale comprises 20 statements. It is a 
Likert-type instrument, with scores ranging from 1 (not at 
all) to 4 (extremely) for STAI-E, and from 1 (almost never) to 
4 (almost always) for STAI-T. The total score of each scale 
ranges from 20 to 80. Higher values  indicate higher levels 
of anxiety.
C) Beck Depression Inventory (BDI) .19 It contains 21 state-
ments that refer to cognitive and affective symptoms, so-
matic sensations and performance. Each statement consists 
of four alternatives that express levels of depressive symp-
toms. The higher the score, the higher the severity.
Procedures
We performed a survey of clinical records of fibromyalgia pa-
tients seen at a teaching clinic linked to a medicine course 
at a university in the city of Santos, SP. After identification, 
contact was made with patients to explain the purpose of the 
research. Of the 40 identified patients, 25 were interested in 
collaborating with the study. The non-FM group participants 
were clinically evaluated to confirm the absence of specific 
symptoms of fibromyalgia. For both groups the instruments 
were administered individually in a single session, in the se-
quence as they were described. Each session lasted approxi-
mately 40 minutes.
Data analysis
Descriptive (mean, standard deviation) and inferential analy-
ses of the variables studied – Lipp Inventory of Stress Symp-
toms for Adults (LISS), State-Trait Anxiety Inventory (STAI), 
Beck Depression Inventory (BDI) – were performed. To com-
pare the two groups of interest with respect to the numeric 
variables, we used the Student t test for unrelated samples. 
Regarding the presence of stress in the scores, the compari-
son between the groups was performed using the Fisher ex-
act test. In studying the association between stress, anxiety 
and depression, the Pearson linear correlation coefficient was 
used, and these were assumed as strong correlations when r ≥ 
0.70.20,22 It should be noted that although the STAI instrument 
measure trait and state anxiety, in the case of correlational 
analysis we considered the trait, by referring to relatively sta-
ble individual differences with respect to the propensity to 
anxiety.21
Results
The mean age of both groups was 49.36 years for fibromyal-
gia (FM) group and 49.20 years for non-fibromyalgia (non-FM) 
group. Table 1 shows the descriptive statistics of the variables 
studied: anxiety (state and trait), stress, depression.
The data in Table 1 show that the FM group had higher 
and statistically different means in anxiety scores (state and 
trait), depression and stress in the three phases, compared 
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Table 2 – Description of absence or presence of stress, 
and their respective phase and symptom.
Stress FM  
n %
non-FM 
n %
p
Absence of stress 1 (4%) 20 (80%) 0.001
Presence of stress 24 (96%) 5 (20%)
Phase
Alert phase (Q1) 1 (4 %) 0 0.157
Resistance phase (Q2) 10 (42%) 5 (100%)
Near-exhaustion phase (Q2) 9 (37%) 0
Exhaustion phase (Q3) 4 (17%) 0
Symptoms
Physical 6 (25%) 1 (20%) 0.319
Psychological 13 (54%) 2 (40%)
Physical and Psychological 5 (21%) 2 (40%)
Table 3 – Pearson linear correlation coefficients for variables: stress, anxiety and depression.
Variables considered  FM non-FM
Coefficient Confidence interval Coefficient Confidence interval
STAI T LISS 0.497 0.127 0.746 0.456 0.074 0.721
BDI 0.408 0.015 0.691 0.678 0.387 0.846
LISS BDI 0.636 0.322 0.824 0.793 0.580 0.905
STAI – T, Trait Anxiety Inventory – Trait; BDI, Beck Depression Inventory; LISS, Lipp Inventory of Stress Symptoms for Adults.
with non-FM group. The mean of trace state in FM indicates 
that symptoms of anxiety are important and clinically signifi-
cant. The BDI mean for FM (21.48) suggests the presence of 
moderate depression, while in non-FM indicates absence of 
depression. With respect to stress, the FM means of the three 
phases were superior to the limits established in the three 
sectors, indicating presence of stress. In non-FM, the scores 
were below the limits established in the three sectors.
With the results obtained, we can say that FM had higher 
means versus non-FM for the following variables: STAI - E (8.8 
points on average); STAI - T (16.3 points); LISS Q1 (5.5 points); 
LISS Q2 (5.8 points); LISS Q3 (8.8 points), BDI (14 points).
Table 2 shows the distribution of stress, phase and symp-
tomatology in the sample.
As can be seen in Table 2, the LISS result shows that 96% of 
the FM participants exhibit stress. For the participants of non-
FM group, this value was 5% (p = 0.001). There was no statisti-
cal difference with respect to the stress phase (p = 0.157) and 
symptomatology (p = 0.319).
The resistance phase was predominant for FM (42%) and 
non-FM (100%) groups. While in FM the participants exhib-
ited stress in the four phases described in LISS (with the 
highest concentration in the two intermediate phases), all 
participants of non-FM group were in the resistance phase. 
With regard to the prevalence of symptoms in the physical 
or psychological area, in the FM group there was a predomi-
nance of psychological symptoms. In the non-FM group, two 
symptomatologies were predominant: psychological (40%) 
and physical and psychological (40%).
Table 3 presents the correlation between the variables 
stress, anxiety (trait) and depression.
The data in Table 3 show the correlation between the 
variables stress, anxiety and depression, both for FM as for 
non-FM group. In the FM group, moderate correlation be-
tween stress and depression was noted (r = 0.636, CI [0.322, 
0.824]). In non-FM, a strong correlation between the vari-
ables stress (LISS) and depression (BDI) (r = 0.793, CI [0.580, 
0.905]) and a moderate correlation between anxiety trace 
(STAI – T) and depression (BDI) (r = 0.678, CI [0.387, 0.846]) 
were observed.
Discussion
In the present study the incidence of anxiety and depression 
in fibromyalgia patients was observed, confirming previous 
studies on this topic.2,3,5,8,9 The results support the relevance 
of further investigations on stress and on the emotional vari-
ables related to this problem in this population.
Among the participants of FM group, trait anxiety was 
significant (52.96 for a total of 80), being higher than state 
anxiety (42,88). This fact allows us to assume the existence 
of a relatively stable cognitive-affective and anxious-behav-
ioral pattern, featuring a trait. This situation differs from the 
state of anxiety, in which the conveyed anxiogenic reactions 
are due to something circumstantial.21 Additionally, the ten-
sional state characteristic of participants with fibromyal-
gia helps us to explain the increased sensitivity to pain.13 
To this, we may add the feeling of fatigue, muscle tension, 
and disturbed sleep (symptoms commonly present in fibro-
myalgia patients), which pertains to the symptomatology of 
some anxiety disorders, such as, for example, Generalized 
Anxiety Disorder.23 Such considerations make it clear how 
the evaluation of the event has an impact on emotional re-
actions and in the symptomatology of different syndromes 
and disorders. 
Regarding the topic of stress, the results showed its oc-
currence in 96% of FM sample, compared to 5% of non-FM, 
corroborating the findings of other studies.3,10 These results 
draw our attention, mainly because fibromyalgia syndrome is 
considered a syndrome of multifactorial etiology with signifi-
cant determination of emotional variables,3,4,8 and this is still 
unclear in the literature. 
The occurrence in all phases of stress and the concentra-
tion in the intermediate phase (resistance and near-exhaus-
tion) observed in FM group made evident the presence of 
signs and symptoms harmful to the functioning and psycho-
social well-being – calling attention to the risk of evolution 
of the stress to the stage of exhaustion, that was identified 
in 4% of this population. Only one member of this group in-
dicated stress in the alert phase, considered as the positive 
phase. However, it should be emphasized that, being the 
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stress a process, the continuity of the stressor action can 
trigger the presentation of the subsequent stages, marked 
by feelings of physical and mental exhaustion, as well as by 
the emergence of diseases.13 Although only 4% of the sam-
ple have exhibited the exhaustion phase, such a finding is 
worrisome, considering that at this stage there is a break of 
resistance, with emergence of some symptoms of the alert 
phase with different intensity and a greater degree of com-
mitment. Additionally, there is the emergence of depression, 
anxiety symptoms and physical exhaustion.13 It can be argued 
that near-exhaustion and exhaustion phases are worrying. At 
this stage, it is common an oscillation between moments of 
well-being and emotional distress.13,18 There was not statis-
tical difference regarding the phase and symptomatology of 
stress, and the correlations between the variables in the FM 
group were moderate or weak. However, the predominance 
of psychological symptoms among participants in this group 
(54%) demonstrates clinical relevancy, making clear the im-
pact of cognitive and emotional variables in the emergence 
and maintenance of this syndrome. It is possible to assume 
that emotional reactions favor the exacerbation of physical 
symptoms.
Final considerations
In the present study, it was shown that stress presents itself 
as an important issue in the investigation of psychological 
factors related to fibromyalgia among women. The identifi-
cation of stress phases (alarm, resistance, near-exhaustion 
and exhaustion) and of its predominant symptoms (physical, 
psychological, physical and psychological) is of fundamental 
importance in the understanding and definition of therapy 
to be used. The finding that trait anxiety is clinically relevant 
(score above 50) is also noteworthy. Its presence allows us to 
assume the existence of distorted cognitive patterns in the 
process of interpreting reality. This finding is significant in 
the understanding of pain syndrome in fibromyalgia patients, 
and may present as an important variable in the physician-
patient relationship.
The diagnosis of moderate depression in FM research rein-
forces the importance of stress,3,8,10 considering complaints of 
reduced energy, decreased activity, impaired ability to experi-
ence pleasure, sleep problems and the existence of fatigue, 
even after minimum effort. 
The understanding of the emotional variables involved in 
fibromyalgia may also enable a more appropriate and compre-
hensive treatment, with implications: 1) social, since it would 
allow the improvement of interpersonal relationships and 
quality of life, 2) economic, since the indexes of occupational 
absenteeism could be reduced; 3) in public health policy, re-
ducing the number of medical consultations and medication 
use. In this sense, we suggest that studies of these variables 
related to fibromyalgia be performed.
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Erratum
There is an error on the year on the headings of issue 1 of 
volume 54 of Brazilian Journal of Rheumatology: in all pag-
es, where it reads: REV BRAS REUMATOL 2013;54(1): and the 
number of the pages, it should read: REV BRAS REUMATOL 
2014;54(1): and the number of the pages
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